The US healthcare market is valued at $2.8 trillion, with diagnostic testing directing 70% of all spend (1, 2). To put that into perspective, 13% of US gross domestic product (GDP), or 13 cents of every dollar, is guided by what occurs at the tip of a needle, urine cup, or specimen vial. FactorOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.